ASK REDCHAT ANYTHING ABOUT FENNEC PHARMACEUTICALS INC.
Fennec Pharmaceuticals Inc. (NASDAQ: FENC)
Listen to this Section
$8.71
-0.4550
(
-4.97% )
61.4K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| PEDMARK™ (sodium thiosulfate)DetailsHearing loss |
Approved |
Market Data
|
| Open |
$8.71 |
| Previous Close |
$9.16 |
| Volume |
61.4K |
| Market Cap |
$317.50M |
| Day Range |
$8.69 - $9.53 |
| 52 Week Range |
$5.65 - $10.45 |
| Shares Outstanding |
34.74M |
| Change % |
-4.97% |
| Net Change |
▼ -0.4550 |
| Insider Ownership |
-0.11% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Pharmaceuticals and Biotechnology |
| IPO Year | 2002 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-900,726.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2023-11-03 |
Sale |
-74793.00 |
Raykov Rosty |
| 2023-08-18 |
Sale |
-673.00 |
RALLIS CHRIS A |
| 2023-08-07 |
Sale |
-200000.00 |
Haigh Adrian |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 424b5 |
Other |
2 |
Nov 17, 2025 |
| 8-k |
8K-related |
19 |
Nov 17, 2025 |
| 10-q |
Quarterly Reports |
63 |
Nov 13, 2025 |
| 424b5 |
Other |
3 |
Nov 13, 2025 |
| schedule |
Other |
1 |
Nov 13, 2025 |
| 4 |
Insider transactions |
1 |
Nov 06, 2025 |
| 4 |
Insider transactions |
1 |
Nov 03, 2025 |
| 4 |
Insider transactions |
1 |
Nov 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 14, 2025 |
| 4 |
Insider transactions |
1 |
Oct 09, 2025 |